Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 169

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 169
---
the “Exchange Notes”), (c) the exercise
of Series A warrants to purchase Class A Ordinary Shares (the “Series A Warrants”), (d) the exercise of Series B warrants
to purchase Class A Ordinary Shares (the “Series B Warrants”), (e) the exercise of Series C warrants to purchase Class A
Ordinary Shares (the “Exchange Warrants and together with the Series A Warrants, and the Series B Warrants, the “Warrants”),
and (f) the New CB Initial Note. We are registering the Resale Shares to satisfy certain registration rights that we have granted to
the Selling Securityholders.

The Selling Securityholders
may from time to time offer and sell any or all of the securities set forth below pursuant to this prospectus. When we refer to the “Selling
Securityholders” in this prospectus, we mean the persons listed in the tables below, and the pledgees, donees, transferees, assignees,
successors and others who later come to hold any of the Selling Securityholders’ interest in our securities after the date of this
prospectus.

The table below presents
information regarding the Selling Securityholders and the Resale Shares that they may offer from time to time under this prospectus.
This table is prepared based on information known to us as of 9, 2025. The number of shares in the column “Maximum Number of Ordinary
Shares to be Sold Pursuant to this Prospectus” represents all of the Class A Ordinary Shares that the Selling Securityholders may
offer under this prospectus. The Selling Securityholders may sell some, all or none of its shares in this offering. We do not know how
long the Selling Securityholders will hold the shares before selling them, and we currently have no agreements, arrangements or understandings
with the Selling Securityholders regarding the sale of any of the shares.

Beneficial ownership is determined
in accordance with Rule 13d-3(d) promulgated by the SEC under the Exchange Act, and includes Class A Ordinary Shares with respect to
which a Selling Securityholder has voting and investment power. The percentage of Class A Ordinary Shares beneficially owned by the Selling
Securityholder prior to the offering shown in the table below is based on an aggregate of 2,952,702 Ordinary Shares outstanding
as of October 31, 2025. The fourth column assumes the sale of all of the shares offered by the Selling Securityholder pursuant to this
prospectus.